USP–Ghana (CePAT)

USP and Ghana officials cut the ribbon to officially open CePAT in Accra

USP–Ghana is home to the Center for Pharmaceutical Advancement and Training (CePAT), a USP Global Health Impact Program. Launched in 2013, CePAT provides high-quality analytical and training services to help strengthen the capacity of national regulatory authorities to detect falsified and substandard medicines, and of local manufacturers to sustainably ensure quality-assured medicine. 
USP-Ghana primarily serves Sub-Saharan Africa—a region seriously threatened by poor quality medicines proliferation. The site is rapidly expanding while strengthening its training and testing capabilities to help ensure that only quality, safe and beneficial medicines are available to patients in Africa. Since its opening, CePAT has trained approximately 190 professionals from 32 African countries on a wide-range of pharmaceutical regulatory, quality assurance and quality control functions. In addition to providing training, CePAT screens pharmaceuticals for quality from across the sub-region.


The USP–Ghana facility contains both office and laboratory space. It is included under USP's ISO 9001:2008 certification and has earned accreditation to IS0 17025:2005. A pharmaceutical microbiology laboratory was recently added, enhancing the site’s quality control testing capabilities. View USP’s ISO certificates.


No. 3 Park Avenue
Motorway Extension
North Dzorwulu
P.O. Box WY 1204, Kwabenya
Accra, Ghana
Phone: +233-30-2216888


For CePAT: Patrick Lukulay, V.P., Global Health Impact Programs-Africa,
For USP-Ghana and USP’s Global Health Impact Programs: Kelly Willis, S.V.P., Global Public Health,


CePAT offers an integrated platform of training and testing services to professionals in the pharmaceutical regulatory and manufacturing sectors. The Center’s comprehensive approach to skills-building and human resource capacity development covers areas critical to achieving and sustaining systemic and lasting improvements, including quality management systems (QMS), good laboratory practices (GLP), good manufacturing practices (cGMP), and quality control (QC) procedures. CePAT also offers third-party testing of medicines to governments and global health initiatives and provides consulting services on supply chain integrity to help partners prevent and detect adulteration of medicines.

Upcoming CePAT Courses

To register for CePAT courses, contact Neimatu Adjabui at

  • Medicines Registration & Dossier Compilation 3 (formerly Dossier Evaluation), Session II: February 29-March 11, 2016
  • Quality Control 3, Session II: May 9-20, 2016
  • Good Manufacturing Practices 4, Session I: July 11-22, 2016
  • Quality Control 4, Session I: November 14-2, 2016

Additional Courses 

These 3-to-5-day courses help build skills in specific technical areas and are offered to professionals servicing the pharmaceutical regulatory and manufacturing sectors, as well as university students wishing to prepare for a career in the pharmaceutical industry.
Analytical method validation
Annual product quality review
Calibration of dissolution test apparatus
Comparative dissolution studies
Developing and implementing a stability program
Dissolution method development and validation
Equipment preventive maintenance
HPLC & GC analytical method development (prior to validation)
In-process materials hold time studies
Inspection reporting
Manufacturing process validation
Medical devices
Microbial testing (since the lab is in progress)
Packaging materials specification and test procedures development
Qualification of existing analytical equipment
Quality management systems
Stability studies/testing
Temperature mapping studies
CePAT is registered with the Council for Technical and Vocational Education and Training in Ghana as a technical education and training provider. Selected courses are recognized as continuing professional development courses by the International Register of Certified Auditors, a division of Chartered Quality Institute, the leading body for quality management professionals in the United Kingdom.

Recent News